2017 American Transplant Congress
Extending the Limit for Living Donor Liver Transplantation: Similar Outcomes After Left vs. Right Lobe Graft, a Propensity Score Analysis.
Surgery, The University of Hong Kong, Hong Kong, Hong Kong
BackgroundThis study aimed to investigate the impact of graft selection (left vs. right lobe) in LDLT.MethodThis was a retrospective study that included all patients who…2017 American Transplant Congress
Novel Personalized Immune-Monitoring Assay for Predicting Operational Tolerance by Using Humanized Mouse Model.
Background: Biomarkers and immune-monitoring assays predicting operational tolerance in transplant recipients have not been established. Our aim was to develop an immune-monitoring assay to address…2017 American Transplant Congress
Prolonged Cold Ischemia Time as a Risk for Low Regeneration at the Early Phase After Living Donor Liver Transplantation.
Background. The objective of this study was to determine the risk factors for low liver regeneration at the early phase after living donor liver transplantation…2017 American Transplant Congress
The Cumulative United States Experience with Transplants (Txs) from Living Donors (LDs): 140,156 LD Txs in 28 Years.
Background/Purpose: Solid organ txs from LDs provide better outcome results than from DDs. We analyzed the cumulative US LD tx experience since UNOS inception. The…2017 American Transplant Congress
Recovery from Hypophosphatemia as a Predictor of Post-Operative Morbidity in Live Donor Hepatectomy.
OBJECTIVE: Live donor hepatectomy (LDH) is associated with significant post-operative hypophosphatemia (POH), which is associated with liver regeneration. We investigated whether the rate of recovery…2017 American Transplant Congress
Technical Refinement to Prevent Hepatic Outflow Disturbance in Right Lobe Living Donor Liver Transplantation: Simplified One-Orifice Venoplasty.
Department of Surgery, Catholic University of Daegu College of Medicine, Daegu, Republic of Korea
Middle hepatic vein (MHV) reconstruction is often essential to avoid hepatic congestion and serious graft dysfunction in living donor liver transplantation (LDLT). The aim of…2017 American Transplant Congress
Patency of Autologous Portal Vein “Y“ Graft in Anterior Sector Outflow Reconstruction in Adult Living Donor Right Lobe Grafts.
Anetrior sector outflow reconstruction is followed by most centers performing right lobe liver transplantation. Recanalised umbilical vein, cryopreserved cadaveric veins/ arteries, PTFE and Recipient's portal…2017 American Transplant Congress
Live Donor Liver Transplantation Using Grafts with More Than Two Bile Ducts – Does It Affect Patient Outcome?
Multi Organ Transplant Program, Department of Surgery, Toronto General Hospital, Toronto, ON, Canada
Introduction: It's been described that the use of live donor (LD) liver grafts with multiple bile ducts (BD) increases the risk of BD related complications…2017 American Transplant Congress
Safety of Liver Donation from Living Donors with Sickle Cell Trait.
Background:Living donor liver transplant (LDLT) is an important source of organs particularly with the cadaveric organ shortage. It is the main source of liver transplant…2017 American Transplant Congress
ABO-Incompatibility Using Ritiuximab Does Not Increase Hepatocellular Carcinoma Recurrence After Liver Transplantation.
Background and aims: ABO-incompatible (ABO-I) living donor liver transplantation (LDLT) has a high success rate. However, a difference in hepatocellular carcinoma (HCC) recurrence rates has…
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 18
- Next Page »